Sign In
Buy BBH
$185.77
+4.04 (+2.22%)
At Close: Jun 03, 2026
Should You Invest in the VanEck Biotech ETF (BBH)?
07:21am, Monday, 11'th May 2026
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on December 20, 2011.
Beyond Tech Industry: Here's how Biotech ETFs Are Riding the AI Wave
10:42am, Monday, 16'th Mar 2026
IBB and other biotech ETFs are gaining traction as AI reshapes drug discovery, genomics, and clinical trials, giving investors diversified exposure to biotech innovation.
Should You Invest in the VanEck Biotech ETF (BBH)?
07:21am, Tuesday, 10'th Mar 2026
Launched on December 20, 2011, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.
BBH Survey Highlights Global Shift to Active & Thematic ETFs
04:46pm, Tuesday, 03'rd Mar 2026
The 2026 Brown Brothers Harriman (BBH) Global ETF Investor Survey revealed a constant data point — demand for ETFs remains robust on a global scale. However, the current market environment is shifti
Short Interest in VanEck Biotech ETF (NASDAQ:BBH) Increases By 107.2%
04:10am, Sunday, 01'st Mar 2026
VanEck Biotech ETF (NASDAQ: BBH - Get Free Report) was the recipient of a large growth in short interest in the month of February. As of February 13th, there was short interest totaling 14,260 shares,
VanEck Biotech ETF (NASDAQ:BBH) & Compass Diversified (NYSE:CODI) Financial Survey
02:32am, Thursday, 12'th Feb 2026
VanEck Biotech ETF (NASDAQ: BBH - Get Free Report) and Compass Diversified (NYSE: CODI - Get Free Report) are both small-cap finance companies, but which is the superior business? We will contrast the
BBH: Mature Biotech Exposure, But Limited Growth Ahead
04:26pm, Wednesday, 21'st Jan 2026
BBH: Mature Biotech Exposure, But Limited Growth Ahead
Should You Invest in the VanEck Biotech ETF (BBH)?
07:21am, Tuesday, 06'th Jan 2026
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on December 20,
VanEck Announces Year-End Distributions for VanEck Equity ETFs
08:24pm, Friday, 19'th Dec 2025
NEW YORK--(BUSINESS WIRE)--VanEck announced today the 2025 annual distributions per share for its VanEck equity exchange-traded funds.
Boston Research & Management Inc. Lowers Stock Holdings in VanEck Biotech ETF $BBH
03:55am, Sunday, 23'rd Nov 2025
Boston Research and Management Inc. lessened its holdings in shares of VanEck Biotech ETF (NASDAQ: BBH) by 4.4% during the second quarter, according to the company in its most recent filing with the S
Should You Invest in the VanEck Biotech ETF (BBH)?
07:21am, Tuesday, 04'th Nov 2025
The VanEck Biotech ETF (BBH) was launched on December 20, 2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the equity marke
AMG and Brown Brothers Harriman Announce Strategic Collaboration
06:59am, Wednesday, 01'st Oct 2025
BBH and AMG to Partner in Developing New Products for the U.S. Wealth Marketplace, Leveraging BBH's Industry-Leading Structured and Alternative Credit Expertise and AMG's Proven Product Development an
Real assets in biotech serving big markets the Street is finally noticing, says Mizuho's Jared Holz
03:32pm, Wednesday, 03'rd Sep 2025
Jared Holz, Mizuho healthcare strategist, joins 'Power Lunch' to discuss the change in sentiment in the healthcare sector, the differences in the biotech ETFs and much more.
BBH Vs. IBB: How To Prepare For The Next Biotech Growth Cycle With BBH
08:03am, Monday, 01'st Sep 2025
Biotech is entering a new growth cycle driven by AI and CRISPR innovation, but current ETF valuations are high and volatility is elevated. BBH offers a concentrated portfolio of leading innovators wit
Should You Invest in the VanEck Biotech ETF (BBH)?
07:21am, Monday, 01'st Sep 2025
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on December 20,
